The New Path to Patient-Driven Treatments and Cures
An increasingly connected world demands an equally connected system for medical solutions.
WITH THE FREEDOM TO CHOOSE
Patients are empowered when they can take an active role in their management of health and become stakeholders in the technologies that drive it. Acting as a bridge between patients and innovators creating tomorrow’s next breakthrough, Aevolve is able to provide patients with the industry’s cutting-edge innovations at the moment it becomes possible for the patient to receive it. Aevolve’s platform gives patients the ability to stand first in line with the innovators changing medicine as we know it and become part of a historic moment.
INDEPENDENT BIOTECH COMPANIES
Where previously, independent biotech innovators would find great difficulty competing with their massive rivals, they can now receive the support they need to grow and reach market availability, while never sacrificing science in favor of business growth. Aevolve is facilitating the next wave of life-changing technologies by allowing the patients who will eventually receive the treatments to be stakeholders in the technologies they’re depending on.
NEXT GENERATION INVESTMENT PRODUCTS
Investment in blockchain technologies and cryptocurrency remains a niche around the world due to poor public image and regulatory uncertainty. However, AVEX.AI represents the next generation of digital assets as it combines the promise and innovation of cryptocurrency, with the security and confidence of a traditional asset in the form of a classic tracker certificate on the Swiss Stock Exchange (The Six).
A New Channel
BRIDGING STAKEHOLDERS IN THE HEALTH INDUSTRY
Aevolve’s model allows more equitable participation and representation among investors, innovators, and patients. It is a channel for greater communication among stakeholders in the health industry. Most of all, it allows patients to take charge of their own health decisions, with the aid and support of a global community.
Preservation of Equity
MORE VALUE. MORE LEVERAGE.
Aevolve allows innovators more diversified sources of capital and opportunities to accelerate value. These new abilities deliver leverage and open ways to preserve ownership and reach their innovation goals.
THE NEW PATH TO PATIENT-DRIVEN TREATMENTS AND CURES
Aevolve is a protocol that supports medical innovations from R&D stages to full-scale commercialization, by connecting patients, investors, and scientific innovators.
FOR PATIENTS AND INNOVATORS
This innovation marketplace connects patients and the global community directly with scientific innovators and experts from all over the world to address various stages of the innovation life cycle.
INVESTOR ACCESS TO A BILLION-DOLLAR ECOSYSTEM
This new asset class provides exposure to opportunities in blockchain, free of the risks associated with previous token offerings. Coming soon to the the SIX Swiss Stock Exchange.
AVEX! Token & The Aevolve Protocol
Cutting-edge medical science meets blockchain-driven technology to create new opportunities to drive innovation.